CVE-2003-0217
Cross-site scripting (XSS) vulnerability in Neoteris Instant Virtual Extranet (IVE) 3.01 and...
Cross-site scripting (XSS) vulnerability in Neoteris Instant Virtual Extranet (IVE) 3.01 and earlier allows remote attackers to insert arbitrary web script and bypass authentication via a certain CGI script.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in Neoteris Instant Virtual Extranet (IVE) 3.01 and earlier allows remote attackers to insert arbitrary web script and bypass authentication via a certain CGI script.
- Record
CVE-2003-0217- CVSS 2.0
- 6.8 Medium
AV:N/AC:M/Au:N/C:P/I:P/A:P - Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in Neoteris Instant Virtual Extranet (IVE) 3.01 and earlier allows remote attackers to insert arbitrary web script and bypass authentication via a certain CGI script.
- Record
CVE-2003-0217- Updated
- 2026-11-02
EUVDEUVD-2003-0212 No score
Cross-site scripting (XSS) vulnerability in Neoteris Instant Virtual Extranet (IVE) 3.01 and earlier allows remote attackers to insert arbitrary web script and bypass authentication via a certain CGI script.
- Record
EUVD-2003-0212- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-frv9-hw3w-2p65 No score
Cross-site scripting (XSS) vulnerability in Neoteris Instant Virtual Extranet (IVE) 3.01 and...
Cross-site scripting (XSS) vulnerability in Neoteris Instant Virtual Extranet (IVE) 3.01 and earlier allows remote attackers to insert arbitrary web script and bypass authentication via a certain CGI script.
- Record
GHSA-frv9-hw3w-2p65- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2003-0217 is a medium vulnerability (CVSS 6.8) in Neoteris Instant Virtual Extranet, published May 14, 2003. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.32%, the 71st percentile. No source names a fixed version.